<- Go Home

Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services. Further, the company provides advisory services. It serves pharmaceutical companies, pharmacies, veterinarians, hospitals, healthcare providers, special stores, retailers, and e-commerce companies. The company was founded in 1907 and is headquartered in Espoo, Finland.

Market Cap

EUR 183.4M

Volume

93.8K

Cash and Equivalents

EUR 152.2M

EBITDA

EUR 11.0M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 167.4M

Profit Margin

8.78%

52 Week High

EUR 1.26

52 Week Low

EUR 0.95

Dividend

7.07%

Price / Book Value

1.82

Price / Earnings

-6.60

Price / Tangible Book Value

3.16

Enterprise Value

EUR 101.6M

Enterprise Value / EBITDA

-12.24

Operating Income

EUR 2.5M

Return on Equity

23.23%

Return on Assets

0.17

Cash and Short Term Investments

EUR 152.2M

Debt

EUR 70.4M

Equity

EUR 100.8M

Revenue

EUR 1.9B

Unlevered FCF

EUR 61.6M

Sector

Health Care Providers and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches